Pharmaceutical-Grade SERM for Laboratory Analysis
Tamoxifen Citrate is a non-steroidal selective estrogen receptor modulator (SERM) manufactured by AstraZeneca under the brand name Nolvadex. This established pharmaceutical compound serves as a reference standard in estrogen receptor research and endocrine pathway investigations. Researchers at Stroid UK Shop can examine this SERM’s competitive antagonist properties at estrogen receptors, particularly in breast tissue models, while observing its agonist activity in bone and endometrial research systems.
Investigational Applications in Laboratory Studies
Scientists investigate tamoxifen citrate’s mechanism as a competitive estrogen receptor antagonist across various tissue-specific research models. The compound demonstrates tissue-selective activity, functioning as an antagonist in breast tissue while exhibiting agonist properties in bone and endometrial systems. Research applications include examining estrogen receptor binding dynamics, studying endocrine pathway modulation, and analysing hormonal receptor selectivity. Investigators studying aromatase inhibitor mechanisms often utilise tamoxifen as a control compound to compare with non-steroidal aromatase inhibitors and alternative SARM compounds in receptor binding assays. Studies examining endocrine disruption, receptor pharmacology, and hormonal signalling pathways frequently incorporate this reference standard. Research laboratories also evaluate tamoxifen’s interactions with other compounds in combination studies, particularly when investigating synergistic effects with peptide-based modulators or other hormonal pathway compounds.
Laboratory Specifications
| Parameter | Value |
|---|---|
| CAS Number | 54965-24-1 |
| Molecular Formula | C₃₂H₃₇NO₈ |
| Molecular Weight | 563.64 g/mol |
| Classification | Non-steroidal SERM |
| Manufacturer | AstraZeneca |
| Storage Requirements | Room temperature, protect from light |
| Research Applications | Estrogen receptor studies, endocrine pathway analysis |
Research Compliance Statement
This tamoxifen citrate product is manufactured by AstraZeneca exclusively for in-vitro laboratory research applications. The compound is intended solely for qualified researchers conducting studies on estrogen receptor mechanisms, endocrine pathway analysis, and related biochemical investigations. This material is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must handle this compound according to institutional safety protocols and maintain proper documentation for all experimental procedures. Purchase and use of this product confirms agreement to research-only applications in compliance with applicable laboratory regulations.
